Rebecca Crews just shocked the world by revealing that groundbreaking focused ultrasound has transformed her life. After 11 years battling Parkinson’s disease, the performer says she can finally write her name and walk without assistance. What this FDA-approved procedure means for millions of patients worldwide.
🔥 Quick Facts
- Diagnosis: Rebecca diagnosed with Parkinson’s in 2015 after 4 years of mysterious symptoms
- Treatment: Bilateral focused ultrasound using MRI-guided sound waves, approved by FDA in July 2025
- Results: Tremors drastically reduced within hours, regained grip strength and handwriting control
- Next step: She will undergo second procedure on left side of brain in September 2026
The Hopeless Morning That Changed Everything
Rebecca hit rock bottom last July, kneeling by her bed in tears after sleepless nights plagued by tremors and despair. She was ready to give up on life itself. That’s when Terry Crews, her husband of 36 years, walked in with news about a revolutionary new Parkinson’s treatment that had just received FDA approval. He reminded her of a parable about a man who rejected rescue boats, waiting instead for a miracle.
“Becky, don’t miss your boat,” Terry told her. Those words shifted everything. Eight months later, Rebecca had undergone the cutting-edge procedure at Stanford Hospital and was finally ready to speak publicly about her journey. She’s confident this technology could offer hope to countless others suffering in silence.
How Focused Ultrasound Actually Works Inside the Brain
The procedure Rebecca underwent is called bilateral focused ultrasound, a non-invasive surgery that took five hours to complete in the MRI scanner. Doctors use a device called Exablate Neuro, created by company Insightec, to fire precisely directed sound waves into the brain. These waves target the exact region responsible for Parkinson’s tremors, stiffness, balance problems, and sleep disruption.
Dr. Vivek Buch, the Stanford University neurosurgeon who supervised Rebecca’s treatment, explains that the technology “gives patients back control over simple things in life like eating and putting on clothes.” The incision-free procedure requires no surgery, no hospital stay complications, and produces results within hours, not weeks. Even while Terry was in Australia for work, he stayed on the phone monitoring her progress throughout the night.
| Treatment Detail | Information |
| Procedure Name | Bilateral Focused Ultrasound (MRgFUS) |
| Duration | 5 hours per side of brain |
| FDA Approval | July 2025 |
| Results Timeline | Within hours |
Rebecca’s Immediate Results Prove the Impact Is Real
At the hotel near Stanford, Rebecca experienced something she hadn’t felt in over a decade. She stood up and lifted her leg without holding onto anything. Then she picked up a pen and realized she could write her name in perfectly legible handwriting for the first time in years. Before the procedure, both tasks were impossible.
“I noticed it immediately. I could lift my leg without holding onto a table or anything. And then I realized that I could write my name in perfectly legible handwriting. I couldn’t do any of those things before having the procedure.”
— Rebecca Crews, Parkinson’s patient
Why This Treatment Is Game-Changing for the Parkinson’s Community
For the 1.1 million Americans living with Parkinson’s, focused ultrasound represents genuine hope beyond traditional medications and older surgical options like deep brain stimulation. Unlike invasive procedures that require incisions, this technology is completely non-invasive and produces lasting symptom relief. The FDA’s approval in July 2025 was a watershed moment for neurology.
Rebecca’s public announcement carries enormous weight because celebrity testimonies drive awareness and clinical interest. More patients will now seek out this option, more hospitals will invest in the equipment, and more insurance companies will review coverage policies. Her courage in sharing her 11-year battle with Parkinson’s has transformed a private struggle into a public health conversation. The treatment isn’t currently covered by Medicare, however, making accessibility a critical ongoing policy question.
What Comes Next for Rebecca and Parkinson’s Patients Everywhere?
Rebecca will receive the second stage of her treatment in September 2026, targeting the left side of her brain to address remaining symptoms on that side of her body. Terry remains fully committed to supporting her through the journey, having already shaved her head before the first procedure and stayed connected throughout her hospital hours. Their 36-year marriage has become a master class in partnership during medical crises.
Beyond their personal story, the bigger question looms: how quickly will focused ultrasound become available in major medical centers across America? Stanford led the way, but patients shouldn’t have to travel across the country for hope. Will insurance companies expand coverage? Can hospitals without cutting-edge equipment develop partnerships or training programs to bring this technology closer to communities that need it most?
